In the 40 years since the Orphan Drug Act was legislated in the USA, there is a growing understanding of the importance of rare diseases that affect over 30 million Americans. While the situation in Europe is similar, no such awareness exists in many parts of the world such as India which is home to over a quarter of the world’s population. It is time to change that, for the 1.5 billion people in India, and the 8 billion people across the world.
The Bridging RARE Summit 2023 brings together key leaders representing all stakeholders of rare diseases from across the world with a specific focus on the US, and the Indian subcontinent.
Cross Border Patient Engagement
Care Pathways: Screening, Diagnosis, & Treatment options
Digitization of Rare Diseases - Registries, Emerging Markets
DEI & Globalization for Orphan Drugs
Orphan Drug Clinical Trials
Regulatory pathways for Orphan Drugs
Live and in-person at Van Metre Hall, George Mason University
Registrations Details
Harsha Rajasimha, MS Ph.D.
Frank Sasinowski, JD, MPH
(views from patient advocates from the US, EU, and India)
Naveen Baweja
Priyanka Kakkar
Gautam Dongre
Suyog Sathe
Samir Sethi
Dorothea Lantz
Allyson Berent
Plenary keynote
Veronica Moore, MA
Manan K. Shah, MBA, MPAP
Marlene Soto-Riera
Teresa Ginger Davis
Bonnie Schneider
Plenary keynote
Screening, diagnosis, and treatments for rare disease patients – differences across geographies
Reena Kartha, MS, PhD
Madhulika Kabra, MD
Joanne Lumsden, PhD
Harsh Sheth, PhD
Ashish Gupta, MD
Current status and strategies to increase global representation
Subha Madhavan, PhD
Sophia Zilber
Paul Mehta, MD
CEO of ABHA, NHA
Keynotes from the greats
Abbey Meyers Khushi Bridging RARE Award
Indo-US Fusion Entertainment
Banquet Dinner
Vikram Karnani, MS, MBA
Abbey S. Meyers, PhD
Honoree 1: Padmashree Dr. IC Verma
Honoree 2: TBD
Ambassador Taranjit Singh Sandhu (Invited)
Senator Warner (Invited)
Congressman Shri Thanedar (Invited)
Dr. Mani Sreenivas and Team
Recap of Day 1
Reena Kartha, Ph.D
Keynote Address
Regulatory and policy differences in various geographies, and how we can develop a global framework to bring access to treatments everywhere
What are the pathways for rare disease drugs in India?
Peter Marks, MD, PhD
Ministry of Health and Family Welfare, India
Bhaskar Sonowal, MBBS, MBA
Experts from FDA and DCGI
Challenges with conducting rare disease clinical trials in areas other than the Western World, Emphasis on India
Moke Sharma, MBA
Rusty Clayton, DO
Scott Schliebner, MPH
Patient Perspective
Meredith Manning, MBA
Mike Blum, MBA
Matthew Pauls, MBA, JD
Kylie O'Keefe
Keynote Address
Panel Discussion
P.J. Brooks, PhD
Mohua Chakraborty Choudhury, PhD
Dean Suhr, BS
Theresa Strong, PhD
Sheffali Gulati, MD
Volunteer Recognition
Treasurer and Board Member
Nisha Venugopal, Ph.D.
This is an excellent opportunity for you to showcase your work and expand your collaborative network by interacting with rare disease stakeholders including our eminent speakers and panelists from US and India.
The Indo US Bridging RARE Summit Souvenir will be distributed to all attendees. It showcases speaker profiles, the meeting agenda and special sessions, Sponsors, leadership messages, photographs, Sponsor and exhibitor information, and much more.
The souvenir book will be designed to have a final size of 8.5”x 11” which will include a ½” border all around. Please follow the below-listed specifications while submitting your ad.
Files that do not meet these requirements will not be accepted. Quality of printing will depend upon the sharpness of the images used.
LAST DATE FOR SUBMISSIONS: 20 September 2023
Disclaimer: *For information only. IndoUSrare is not affiliated with and does not endorse any of these funding sources. We also do not provide any travel allowances.
This program assists rare disease researchers and professional students with an interest in the rare disease field with travel expenses, and provides opportunities for these individuals to be able to connect in person with the rare disease community, to foster collaboration and communication.